Skip to main content
Figure 3 | Behavioral and Brain Functions

Figure 3

From: Methylphenidate improves prefrontal cortical cognitive function through α2 adrenoceptor and dopamine D1 receptor actions: Relevance to therapeutic effects in Attention Deficit Hyperactivity Disorder

Figure 3

The enhancing effects of methylphenidate were blocked by co-administration of the dopamine D1 receptor antagonist, SCH23390 at doses which had no effect on their own. Results represent mean ± S.E.M. percent correct on the delayed alternation task. VEH = cracker vehicle; MPH = optimal dose of methylphenidate (1.0–3.0 mg/kg); SCH = SCH23390 (0.01 or 0.1 mg/kg); ** significantly different from VEH p = 0.0002; † significantly different from MPH, p = 0.008.

Back to article page

Behavioral and Brain Functions

ISSN: 1744-9081

Contact us